NCT06756711Enrolling by invitation
Combination of Supplements for Treating Autistic Spectrum Disorder
Source: ClinicalTrials.gov · Last updated 3 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A pilot study to compare the efficacy of a combination of apitherapy supplements versus placebo in children with autistic spectrum disorder.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 23 Dec 2024
- Start date
- 10 Dec 2024
- Primary completion date
- Sept 2025
- Lead sponsor
- Fundatia Bio-Forum
- Diseases
- Autism
- NCT number
- NCT06756711
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 10 Dec 2024 to the primary completion date, Sept 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients enrolled in another interventional clinical trial currently or which ended less than 1 month prior to enrolling in this study
- administration of anticoagulants, antiplatelets, thrombolytic agents, low molecular weight heparins, anticonvulsants, insulin, monoamine oxidase inhibitors, non-steroidal anti-inflammatory drugs or thiazide diuretics
Other illness
- known allergy to hive products or one of the substances studied
- diagnosis of diabetes
- history of seizures/epilepsy
- allergy to celery and other plants of the Fam. Apiaceaea (Umbelliferae)
Other
- inability to perform the study requirements (3 visits to the Investigator, 3 psychometric assessments, 3 sets of blood tests)
- abnormally elevated baseline (at V1) values of ferritin, homocysteine, HgbA1c, ESR
Who the study is looking for
- age 3-14 years
- diagnosed with typical or atypical autism spectrum disorder (F84.0 or F84.1) and received at least one therapeutic intervention before enrolling
- the ability to follow an oral treatment, with TID/BID/QD administration
- the availability to perform 3 sets of blood tests at a clinical laboratory within 6 months (initial, at 3- and 6-months)
- the availability to perform 3 visits to the Investigator and 3 psychometric evaluations within 6 months
Age in the registry: 3 years to 14 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Clinica Aide Sante Coordinator of this site? Confirm its status | Bucharest | Romania | Unknown status |
| Medical Link SRL Coordinator of this site? Confirm its status | Constanța | Romania | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.